|
Volumn 26, Issue 1, 2001, Pages 25-31
|
Picroliv: Hepatoprotectant immunomodulator
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
KUTKIN;
PLACEBO;
ADULT;
ARTICLE;
CHEMICAL ANALYSIS;
CHEMICAL REACTION;
CLINICAL TRIAL;
DOSE LIVER FUNCTION RELATION;
DOUBLE BLIND PROCEDURE;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
IMMUNOMODULATION;
LIVER DISEASE;
LIVER FUNCTION TEST;
LIVER PROTECTION;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REACTION ANALYSIS;
SIDE EFFECT;
TREATMENT OUTCOME;
VIRUS HEPATITIS;
|
EID: 0035100044
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.2001.026.01.603287 Document Type: Article |
Times cited : (20)
|
References (86)
|